- Case report
- Open Access
- Open Peer Review
Multiple cerebral sinus thromboses complicating meningococcal meningitis: a pediatric case report
© Bozzola et al.; licensee BioMed Central Ltd. 2014
- Received: 10 February 2014
- Accepted: 27 May 2014
- Published: 13 June 2014
Cerebral venous sinus thrombosis (CVT) is a rare and potentially life-threatening condition in the pediatric population. The clinical presentation is frequently nonspecific; thus diagnosis is often delayed or missed.
A previously healthy 8 month-old boy was diagnosed with meningococcal meningitis. At hospital admission, an urgent non contrast-enhanced computed tomography (CT) of the head and neck was performed with normal results. Ceftriaxone was promptly started and the clinical condition of the patient improved. However, on the 7th day of hospitalization, the child suddenly manifested irritability and lethargy. An urgent contrast-enhanced CT of the head and neck was immediately performed, revealing thrombosis of the superior sagittal, transverse and rectus sinuses. A thrombophilic evaluation was performed, revealing hyperhomocysteinemia and methylenetetrahydrofolate reductase (MTHFR) variants (C677T and A1298C).
The causes of CVT may be categorized into three main groups: hypercoagulable states, conditions causing blood flow disturbances, and all causes of inflammation or infection. In this case report, we observed more than one risk factor that predisposed the patient to CVT. Consequently, even if a causative factor is detected, a thrombophilic blood evaluation should be performed. In fact, in case of a prothrombotic condition, the patient’s family should be advised that prompt administration of anticoagulant is necessary in the event of situations that could lead to thrombosis. Finally, CVT may be considered a possible complication of infection even when recent imaging results are normal. A prompt CVT diagnosis is required to obtain a good outcome. Delayed diagnosis is mainly due to the rarity of the disease and physicians’ unawareness of this type of complication.
- Cerebral venous sinus thrombosis
- Thrombophilic evaluation
Cerebral venous sinus thrombosis (CVT) is a rare, potentially life-threatening disorder that may have vital or morbid consequences, such as motor dysfunction or visual impairment. It predominantly affects adults in their third and fourth decades . Even if high-quality epidemiologic studies are lacking, the available data suggest an incidence of 0.67 cases per 100,000 children per year. The prevalence of childhood CVT varies according to age; neonates are the most commonly affected [2–4].
The signs and symptoms of CVT are frequently nonspecific, often resulting in delayed or missed diagnosis . In fact, CVT may present with a variety of signs and symptoms, including irritability, headache, seizure, encephalopathy, papilledema, cranial nerve palsies, motor weakness and coma . Studies suggest that prompt diagnosis and anticoagulant therapy may improve outcome in the majority of patients [2, 4, 7]. The causes of CVT may be categorized into three main groups according to Virchow’s classification. The first group includes all hypercoagulable states. The second group consists of conditions causing blood flow disturbances. Finally, the third group comprises all causes of inflammation or infection . Among these, prothrombotic conditions, either genetic or acquired, malignancy, and head injury are the most frequent causes. As regards infectious causes of CVT, these are responsible for only 6 to 12 percent of cases . Previous reports have cited sinusitis, otitis, and mastoiditis among the principal predisposing factors. Although the frequency of septic thrombosis is decreasing due to antibiotic development, recent studies have demonstrated that CVT may be a complication of meningitis and sepsis in about 7% and 16% of cases, respectively [2, 7, 10].
We describe the clinical case of a child with multiple sinovenous thromboses occurring after the diagnosis of meningococcal meningitis.
According to the literature, CVT may be caused by hypercoagulable states, by conditions causing blood flow disturbances, or by inflammation/infection . In our case report, we observed more than one risk factor that predisposed to CVT. We speculate that the genetic prothrombotic condition predisposed to CVT, which was triggered by a central nervous system infection. In fact, the CT scan was normal at both meningitis onset and post-discharge follow-up. For this reason, thrombophilic evaluation should be encouraged in all children with CVT, independent of other established risk factors such as meningitis, in order to identify children with increased risk factors for thrombophilia. Thrombophilia may be defined as a high risk for thrombosis, which can be either inherited or acquired. The percentage of patients with CVT who have an identified risk factor for thrombophilia varies significantly from study to study, from 33% to 99% . Moreover, there is no consensus as to which baseline studies should be included in a standard hypercoagulability evaluation . In one report, anticardiolipin antibody was the most common prothrombotic risk factor, while in another the homozygous MTHFR mutation was the most common [2, 8]. A German study reported cases in which either elevated lipoprotein A or protein C deficiency was associated with CVT; in an American study, protein C and antithrombin III deficiencies were common [7, 13]. Other potential procoagulant markers recently considered in CVT include anemia, hyperhomocysteinemia, and factor VIII levels.
In the event of a prothrombotic diagnosis, the patient’s family should be advised to administer drugs (antiplatelet or anticoagulant agents) in situations that could lead to thrombosis. In fact, patients recovering from CVT are at risk of recurrence or other thrombotic event . It should be explained to patients that testing of their first degree relatives for heritable thrombophilia will allow the detection of affected but asymptomatic family members.
Because of its nonspecific presentation, diagnosis of CVT may be delayed and even missed. Clinicians must maintain a high index of suspicion when treating any child with an acute central nervous system infection and presenting neurological signs and symptoms despite administration of appropriate therapy.
Imaging should be considered to rule out intracranial complications. The currently available diagnostic tools include head CT, MRI and MR venogram [4, 6]. Of these, head CT is the most commonly performed examination when sinus thrombosis is suspected . Diagnostic sensitivity is increased with the addition of a postcontrast CT. The empty delta sign, a classic signature of CVT, is present on post-contrast CT in 10% to 30% of cases. On head CT with contrast, the empty delta sign may be seen as a triangular pattern of contrast enhancement surrounding a central region which lacks contrast enhancement in the posterior part of the superior sagittal sinus [2, 4]. A dense cord sign (hyperdense fresh blood clot) is seen on noncontrast head CT in 1% to 5% of cases . A previous normal result, even if performed just a few days prior, should not influence the clinician’s decision to repeat the exam. In case of CVT, follow-up imaging of the venous sinuses is generally performed in order to check thrombosis evolution. The mainstay of CVT treatment is anticoagulation and supportive care. The purpose of anticoagulant therapy is to limit the propagation of an existing clot and to prevent the formation of further thrombi [2, 4]. Previous studies have reported encouraging data on the safety of anticoagulation therapy in children with CVT and on improved cognitive outcome [2, 7]. Although definitive evidence of effectiveness is lacking, there is a general consensus that anticoagulation with unfractionated intravenous heparin or subcutaneous LMWH is appropriate treatment for acute CVT . The treatment most used for infants and children is LMWH for 7–10 days (120-180 UI/kg twice a day in children up to 1 year of age, and 100 UI/Kg twice a day in older patients) followed by oral anticoagulants or antiplatelets generally for 3–6 months . Therapy is generally discontinued 6 months after the acute phase but may be prolonged after hematological evaluation depending on the patient’s age and clinical condition. Instructions to the family at patient’s discharge include the necessity to continue anticoagulation after the acute phase in order to prevent CVT recurrence.
Finally, CVT in children sometimes has a poor prognosis despite prompt diagnosis and therapy. Commonly identified morbidities include motor dysfunction, neuropsychiatric disorders, visual impairment, pseudotumor cerebri, seizures, and headaches . In our case, even though CVT involved multiple sinuses and the child was affected by both meningitis and sepsis, the prognosis was good, with no sequelae at five months follow-up. The early diagnosis led to prompt therapy and consequently enabled a good neurodevelopmental outcome.
Written informed consent was obtained from the patient’s mother for publication of these data and for the accompanying images. A copy of the written consent is available for review by the Editor of this Journal.
The authors are grateful to Mrs Jean Ringrose for revising the English language of the paper.
- Algahtani HA, Aldarmahi AA: Cerebral sinus venus thrombosis. Neurosciences (Riyadh). 2014, 19 (1): 11-16.Google Scholar
- deVeber G, Andrew M, Adams C, Bjornson B, Booth F, Buckley DJ, Camfield CS, David M, Humphreys P, Langevin P, MacDonald EA, Gillett J, Meaney B, Shevell M, Sinclair DB, Yager J, Canadian Pediatric Ischemic Stroke Study Group: Cerebral sinovenous thrombosis in children. N Engl J Med. 2001, 345 (6): 417-423. 10.1056/NEJM200108093450604.View ArticlePubMedGoogle Scholar
- Saposnik G, Barinagarrementeria F, Brown RD, Bushnell CD, Cucchiara B, Cushman M, deVeber G, Ferro JM, Tsai FY, American Heart Association Stroke Council and the Council on Epidemiology and Prevention: Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011, 42: 1158-10.1161/STR.0b013e31820a8364.View ArticlePubMedGoogle Scholar
- Carpenter J, Tsuchida T: Cerebral sinovenous thrombosis in children. Curr Neurol Neurosci Rep. 2007, 7 (2): 139-146. 10.1007/s11910-007-0009-3.View ArticlePubMedGoogle Scholar
- Matar NE, Rassi SJ, Melkane AE, Haddad AC: Lateral sinus thrombosis in the pediatric population: multiple presentations for a potentially lethal disease. Pediatr Emerg Care. 2009, 25 (10): 681-683. 10.1097/PEC.0b013e3181bec90c.View ArticlePubMedGoogle Scholar
- Hedlund GL: Cerebral sinovenous thrombosis in pediatric practice. Pediatr Radiol. 2013, 43 (2): 173-188. 10.1007/s00247-012-2486-z.View ArticlePubMedGoogle Scholar
- Sébire G, Tabarki B, Saunders DE, Leroy I, Liesner R, Saint-Martin C, Husson B, Williams AN, Wade A, Kirkham FJ: Cerebral venous sinus thrombosis in children: risk factors, presentation, diagnosis and outcome. Brain. 2005, 128: 477-489. 10.1093/brain/awh412.View ArticlePubMedGoogle Scholar
- Ferro JM, Canhão P, Stam J, Bousser MG, Barinagarrementeria F: ISCVT Investigators. Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke. 2004, 35: 664-10.1161/01.STR.0000117571.76197.26.View ArticlePubMedGoogle Scholar
- Carvalho KS, Bodensteiner JB, Connolly PJ, Garg BP: Cerebral venous thrombosis in children. J Child Neurol. 2000, 16: 574-580.View ArticleGoogle Scholar
- Fitzgerald KC, Golomb MR: Neonatal Arterial Ischemic Stroke and Sinovenous Thrombosis Associated With Meningitis. J Child Neurol. 2007, 22: 818-10.1177/0883073807304200.View ArticlePubMedGoogle Scholar
- Chan A, de Veber G: Prothrombotic disorders and ischemic stroke in children. Semin Pediatr Neurol. 2000, 7: 301-308. 10.1053/spen.2000.20075.View ArticlePubMedGoogle Scholar
- Mullins M, Grant P, Wang B, Gonzales RG, Schaefer PW: Parenchymal abnormalities associated with cerebral venous sinus thrombosis: assessment with diffusion-weighted MR imaging. Am J Neuroradiol. 2004, 25: 1666-1675.PubMedGoogle Scholar
- Heller C, Heinecke A, Junker R, Knofler R, Kosch A, Kurnik K, Schobess R, von Eckardstein A, Strater R, Zieger B, Nowak-Gottl U, Childhood Stroke Study Group: Cerebral venous thrombosis in children: a multifactorial origin. Circulation. 2003, 108: 1362-1367. 10.1161/01.CIR.0000087598.05977.45.View ArticlePubMedGoogle Scholar
- Coutinho JM, Stam J: How to treat cerebral venous and sinus thrombosis. J Thromb Haemost. 2010, 8: 877-PubMedGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2431/14/147/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.